Imperial College London

DrRichardNicholas

Faculty of MedicineDepartment of Brain Sciences

Professor of Practice (Neurology)
 
 
 
//

Contact

 

r.nicholas

 
 
//

Location

 

12L12CLab BlockCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Ontaneda:2018,
author = {Ontaneda, D and Tallantyre, E and Nakamura, K and Planchon, SM and Miller, DM and Hersh, C and Chaudhry, BZ and Bale, C and Alvarez, E and Chataway, J and Craner, M and Freeman, L and Frost, N and Goldman, M and Hobart, J and Hunt, D and Hutton, G and Hyland, M and Joseph, F and Lily, O and Moses, H and Nicholas, J and Nicholas, R and Overell, J and Pearson, OR and Pomeroy, I and Smith, A and Zabeti, A and Gerry, S and Gunzler, D and Coles, A and LaRocca, N and Gray, E and Cohen, JA and Evangelou, N},
pages = {470--471},
publisher = {SAGE PUBLICATIONS LTD},
title = {Design and rationale of the determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis (DELIVER-MS) trial},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446861401232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2018}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Ontaneda,D
AU - Tallantyre,E
AU - Nakamura,K
AU - Planchon,SM
AU - Miller,DM
AU - Hersh,C
AU - Chaudhry,BZ
AU - Bale,C
AU - Alvarez,E
AU - Chataway,J
AU - Craner,M
AU - Freeman,L
AU - Frost,N
AU - Goldman,M
AU - Hobart,J
AU - Hunt,D
AU - Hutton,G
AU - Hyland,M
AU - Joseph,F
AU - Lily,O
AU - Moses,H
AU - Nicholas,J
AU - Nicholas,R
AU - Overell,J
AU - Pearson,OR
AU - Pomeroy,I
AU - Smith,A
AU - Zabeti,A
AU - Gerry,S
AU - Gunzler,D
AU - Coles,A
AU - LaRocca,N
AU - Gray,E
AU - Cohen,JA
AU - Evangelou,N
EP - 471
PB - SAGE PUBLICATIONS LTD
PY - 2018///
SN - 1352-4585
SP - 470
TI - Design and rationale of the determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis (DELIVER-MS) trial
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446861401232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -